Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
168 hedge funds and large institutions have $1.21B invested in Avid Bioservices, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 19 closing their positions.
37% more capital invested
Capital invested by funds: $885M → $1.21B (+$326M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
0% more funds holding
Funds holding: 168 → 168 (0)
0% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $1.25M
2% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 62
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$8.03M |
| 2 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$6.78M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$6.3M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.16M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$22.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$10.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.88M |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$3.94M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$3.54M |
CDMO Hedge Fund Activity: Q1 2023 in Review
168 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2023, worth a combined $1.21B — up 37% from $885M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CDMO positions and 19 closed out — a net gain of 2 holders — while 61 added to existing stakes and 62 trimmed.
The largest buyer was Geneva Capital Management, adding an estimated $8.03M. The largest seller was State Street, cutting an estimated $22.7M.
- 168 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $1.21B of Avid Bioservices, Inc. Common Stock stock for Q1 2023, up 37% quarter-over-quarter.
- 21 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2023 and 19 closed out, a net change of +2 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2023 was Geneva Capital Management, an estimated $8.03M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2023 was State Street, an estimated $22.7M sold.
Based on aggregated 13F filings for Q1 2023.